BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38128371)

  • 21. Utility of PET/CT in patients with stage I-III melanoma.
    Avilés Izquierdo JA; Molina López I; Sobrini Morillo P; Márquez Rodas I; Mercader Cidoncha E
    Clin Transl Oncol; 2020 Aug; 22(8):1414-1417. PubMed ID: 31873917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
    Hope TA; Eiber M; Armstrong WR; Juarez R; Murthy V; Lawhn-Heath C; Behr SC; Zhang L; Barbato F; Ceci F; Farolfi A; Schwarzenböck SM; Unterrainer M; Zacho HD; Nguyen HG; Cooperberg MR; Carroll PR; Reiter RE; Holden S; Herrmann K; Zhu S; Fendler WP; Czernin J; Calais J
    JAMA Oncol; 2021 Nov; 7(11):1635-1642. PubMed ID: 34529005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
    Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765
    [No Abstract]   [Full Text] [Related]  

  • 24. Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trial.
    Stoffels I; Herrmann K; Rekowski J; Jansen P; Schadendorf D; Stang A; Klode J
    Trials; 2019 Feb; 20(1):99. PubMed ID: 30717811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.
    Oude Ophuis CM; van Akkooi AC; Hoekstra HJ; Bonenkamp JJ; van Wissen J; Niebling MG; de Wilt JH; van der Hiel B; van de Wiel B; Koljenović S; Grünhagen DJ; Verhoef C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1172-80. PubMed ID: 26014150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
    Allan CP; Hayes AJ; Thomas JM
    ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.
    Yuan JB; Zu XB; Miao JG; Wang J; Chen MF; Qi L
    BJU Int; 2013 Jul; 112(2):E87-91. PubMed ID: 23323729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of
    Zhang Q; Zang S; Zhang C; Fu Y; Lv X; Zhang Q; Deng Y; Zhang C; Luo R; Zhao X; Wang W; Wang F; Guo H
    J Transl Med; 2017 Nov; 15(1):230. PubMed ID: 29115970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
    Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A
    Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
    Maurer T; Souvatzoglou M; Kübler H; Opercan K; Schmidt S; Herrmann K; Stollfuss J; Weirich G; Haller B; Gschwend JE; Schwaiger M; Krause BJ; Treiber U
    Eur Urol; 2012 May; 61(5):1031-8. PubMed ID: 22196847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional control after precision lymph node dissection for clinically evident melanoma metastasis.
    Lynch KT; Hu Y; Farrow NE; Song Y; Meneveau MO; Kwak M; Lowe MC; Bartlett EK; Beasley GM; Karakousis GC; Slingluff CL
    J Surg Oncol; 2023 Jan; 127(1):140-147. PubMed ID: 36115028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
    Macfarlane DJ; Sondak V; Johnson T; Wahl RL
    J Clin Oncol; 1998 May; 16(5):1770-6. PubMed ID: 9586890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series.
    Abreu A; Fay C; Park D; Quinn D; Dorff T; Carpten J; Kuhn P; Gill P; Almeida F; Gill I
    BJU Int; 2017 Sep; 120(3):401-408. PubMed ID: 27981731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
    Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer.
    Meijer D; Ettema RH; van Leeuwen PJ; van der Kwast TH; van der Poel HG; Donswijk ML; Oprea-Lager DE; Bekers EM; Vis AN
    BJU Int; 2023 Mar; 131(3):330-338. PubMed ID: 36069585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma.
    Hirshoren N; Olayos E; Herschtal A; Ravi Kumar AS; Gyorki DE
    Otolaryngol Head Neck Surg; 2018 Jan; 158(1):122-126. PubMed ID: 28925330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.